Market revenue in 2023 | USD 465.9 million |
Market revenue in 2030 | USD 756.8 million |
Growth rate | 7.2% (CAGR from 2023 to 2030) |
Largest segment | Paramagnetic |
Fastest growing segment | Paramagnetic |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Paramagnetic, Superparamagnetic |
Key market players worldwide | GE HealthCare Technologies Inc Common Stock, Bayer AG, Guerbet, Bracco, Miltenyi Biotec |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to mri contrast media agents market will help companies and investors design strategic landscapes.
Paramagnetic was the largest segment with a revenue share of 87.62% in 2023. Horizon Databook has segmented the Europe mri contrast media agents market based on paramagnetic, superparamagnetic covering the revenue growth of each sub-segment from 2018 to 2030.
Increasing public and private investments in R&D are some of the significant factors contributing to market growth in Europe. Rising demand for healthcare devices and growing prevalence of chronic & pain-associated disorders in the region are some major drivers anticipated to propel market growth.
In the recent decade, the use of diagnostic imaging modalities, such as MRI, CT, and ultrasound, has increased rapidly in Europe. In 2015, the largest number of MRI scans performed was in France and Germany, where the number of scans per 100,000 people was reported to be higher than 10,000.
In 2017, EMA announced restrictions on sales of certain linear gadolinium contrast agents used in MRI. This was due to safety concerns regarding the accumulation of linear gadolinium agents in the brain. Hence, Magnevist, Omniscan, and Optimark were discontinued in the European market.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe mri contrast media agents market , including forecasts for subscribers. This continent databook contains high-level insights into Europe mri contrast media agents market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account